These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4807231)

  • 21. Long-term use of progestogens--getting the balance right: molecular biology and the endometrium.
    Druckmann R
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():53-61. PubMed ID: 17943540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of estrogen and progestogen on nitric oxide content in rat endometrium.
    Zha YP
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):283. PubMed ID: 12651256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Neves-E-Castro M
    Clin Obstet Gynecol; 2008 Sep; 51(3):607-17. PubMed ID: 18677154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth of leiomyomata with estrogen--progestogen therapy.
    John AH; Martin R
    J Reprod Med; 1971 Feb; 6(2):56-8. PubMed ID: 5115282
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding.
    Rogers PA; Martinez F; Girling JE; Lederman F; Cann L; Farrell E; Tresserra F; Patel N
    Hum Reprod; 2005 Dec; 20(12):3341-7. PubMed ID: 16085661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the problem of a cancerogenic effect of orally administered estrogen-gestagenic-hormonal combinations. A clinical contribution].
    Froewis J; Kremer H
    Wien Klin Wochenschr; 1965 Oct; 77(42):792-8. PubMed ID: 5880480
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
    Hertz R
    Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the side effects of treatment with hormone preparations consisting of estrogen-gestagen combinations].
    Osler M
    Ugeskr Laeger; 1967 Mar; 129(9):294-6. PubMed ID: 5599492
    [No Abstract]   [Full Text] [Related]  

  • 30. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
    Van Campenhout J; Choquette P; Vauclair R
    Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestational agents.
    Br Med J; 1969 Aug; 3(5666):344-6. PubMed ID: 5816498
    [No Abstract]   [Full Text] [Related]  

  • 32. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estrogen and protestational hormone treatment and neuropsychiatric problems].
    Pescetto G
    Sist Nerv; 1969; 21(6):348-62. PubMed ID: 5402451
    [No Abstract]   [Full Text] [Related]  

  • 34. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
    Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.
    McGonigle KF; Karlan BY; Barbuto DA; Leuchter RS; Lagasse LD; Judd HL
    Gynecol Oncol; 1994 Oct; 55(1):126-32. PubMed ID: 7959253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
    Drill VA
    J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estrogen/gestagen-induced hypertension].
    Erichsen GG
    Ugeskr Laeger; 1987 Sep; 149(38):2544-5. PubMed ID: 3451478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.